Bioclonetics
WebI had the pleasure of interviewing Charles Cotropia, CEO and co-founder of BioClonetics Immunotherapeutics, Inc. www.bioclonetics.com a Texas based biotech company. Thank you so much for joining us! Can you tell us a story about what brought you to this specific career path? My educational background is in Law and Aerospace Engineering. WebDec 1, 2024 · BioClonetics Immunotherapeutics, Inc. is a Dallas, Texas biotech company with proprietary technology for producing fully human monoclonal antibodies (mAbs) …
Bioclonetics
Did you know?
WebBioClonetics' antibody-based immunotherapeutics platform can be utilized across both human and animal infectious-disease applications. For example, the technology can be used to produce treatment for … WebDec 1, 2024 · BioClonetics Immunotherapeutics, Inc. is a Dallas, Texas biotech company with proprietary technology for producing fully human monoclonal antibodies (mAbs) …
WebIn agricultural facilities, the definition for “biocontainment” resembles that for “biosafety,” i.e., the safety practices and procedures used to prevent unintended infection of plants or … WebJun 10, 2024 · Jan 1990 - Apr 202428 years 4 months. Retired. Accredited Angel investor providing capital for start-ups and early to later-round financing. Investor in various private corporations and ...
WebMar 15, 2024 · The merger with BioClonetics . On December 1, 202 0, Enzolytics announced that it merged with BioClonetics Immunotherapeutics, a company with technology for producing fully … WebDec 7, 2024 · The Company is now combining this technology with recently acquired technology, created by BioClonetics Immunotherapeutics, for creating fully human anti-monoclonal antibodies for treating HIV. Using …
WebNov 16, 2024 · BioClonetics Immunotherapeutics, Inc. is a Dallas Texas biotech company with proprietary technology for producing fully human monoclonal antibodies (mAbs) against infectious diseases including HIV, …
WebOct 26, 2024 · About BioClonetics Immunotherapeutics, Inc. BioClonetics Immunotherapeutics, Inc. is a Dallas Texas biotech company with proprietary technology … immature 6 year oldWebSep 17, 2024 · BioClonetics was launched in 2009 by co-founders Charles and Joseph Cotropia. The company has developed a technology for the creation of human … list of shipping stocksWebOct 7, 2024 · BioClonetics Immunotherapeutics is a biotechnology company with a proprietary methodology for producing fully human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic ... immature abs granulocytes highWebSep 16, 2024 · BioClonetics is in the final stage of development of a parent monoclonal antibody ("mAbs") (designated as Clone 3), which is non-toxic and has shown in initial … list of shippuden fillersWebHighlights. We have created a cell line that produces an anti-HIV antibody called Clone 3. We have demonstrated that Clone 3 neutralizes all clades and groups of HIV isolates. We have identified that Clone 3 targets HIV … immature acetylcholine receptorsWebOct 19, 2024 · BioClonetics Immunotherapeutics, Inc. is a Dallas Texas biotech company with proprietary technology for producing fully human monoclonal antibodies (mAbs) … list of ship prefixesWebDescription. Developer of monoclonal antibodies intended to treat infectious diseases with non-toxic passive immunotherapy. The company's technology specializes in developing … list of ships built by ingalls